This HND piece is a follow-up to previous postings on this exciting Cannabis extract. Cannabidiol is rapidly growing in popularity because it provides virtually all the medical benefits of Cannabis, without the psychotropic effects. As such, it should be of no interest to the DEA, but may eventually come under the FDA.
Thus, CBD suppliers are encouraged to act as if they already were regulated. Note how the FDA is starting to go hog-wild on e-cigarettes if any further convincing is needed. The piece provides many useful links—especially to research studies on how CBD can benefit sufferers of 46 medical conditions.
Read the complete article.